AFA urges FDA to wait for McNeil raw data on aspirin/alcohol link at "feedback" meeting.
This article was originally published in The Tan Sheet
Executive Summary
AFA URGES FDA TO WAIT FOR McNEIL RAW DATA ON ASPIRIN/ALCOHOL INTERACTION before proposing an alcohol warning on aspirin products. At a July 11 "OTC feedback" meeting, Aspirin Foundation of America outside counsel Bruce Dickson (Washington, D.C. law firm Paul, Hastings, Janofsky & Walker) objected to FDA's plan to require an alcohol warnings on aspirin-containing OTC analgesics ("The Tan Sheet" Jan. 16, p. 3).